Embryo Project Encyclopedia Articles

In 2014, the United States Food and Drug Administration published the Pregnancy and Lactation Labeling Rule to amend previous guidelines for the prescription of drugs for pregnant and lactating women. The 2014 Pregnancy and Lactation Labeling Rule was intended to increase the safety and efficacy of prescription drugs by making drug labels easier for physicians to understand and utilize. The Pregnancy and Lactation Labeling Rule restructured drug labels and required that they include narratives describing drug-associated risks to women and fetuses, rather than using complicated letter categories. The Pregnancy and Lactation Labeling Rule changed the framework for drug labeling, making it easier for doctors to prescribe safe and effective drugs to pregnant women, lactating women, and people of reproductive capacity.

In the 1994 article “The ‘Kangaroo-Method’ for Treating Low Birth Weight Babies in a Developing Country,” authors Nils Bergman and Agneta Jürisoo evaluate the effectiveness of the Kangaroo Care method in treating low birth weight infants at Manama Mission Hospital in Gwanda, Zimbabwe. Low birth weight infants face many medical complications. In developing countries, where the prevalence of low birth weight infants is highest, there is limited access to the technology or skilled personnel required to keep those infants alive. The Kangaroo Care method includes exclusive breastfeeding and skin-to-skin contact on the mother's chest to treat low birth weight infants. In “The ‘Kangaroo-Method’ for Treating Low Birth Weight Babies in a Developing Country,” the authors demonstrate that the method is just as effective as conventional technological methods in treating low birth weight infants.